slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 49,291-49,320
Pages 3,679
Rows per page 30
Component
49,291-49,320 of 110,355
09
The slide includes a footnote clarifying the relationship between core funds and co-investment vehicles.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
13
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
14
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
15
The chart highlights Mondelez's underperformance relative to peers, with Mondelez shown in red.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
16
Uses a timeline to illustrate the accumulation of brands over time.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Problem & ComplicationLoop · Pattern Hunter1 hit
17
The slide uses a comparison frame to expose a gap between Mondelez's performance and the 'gold standard' 3G Capital approach.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Problem & ComplicationLoop · Pattern Hunter1 hit
18
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Problem & ComplicationLoop · Pattern Hunter1 hit
19
The slide uses a before-after comparison to demonstrate operational efficiency gains.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Problem & ComplicationLoop · Pattern Hunter1 hit
21
The chart uses a visual bridge to show the gap between the 2018 target and the activist's 'optimized' projection.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Solution & ApproachLoop · Pattern Hunter1 hit
58
The slide highlights regulatory constraints on direct selling business models in China.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
59
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
60
The slide provides a direct legal citation to establish the regulatory framework for pyramid schemes in China.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
61
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
62
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
63
The slide highlights the specific criteria (30 participants, 3 levels) for criminal liability in China.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
04
This slide serves as a company profile/introductory slide for an activist investor deck.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Setup1 hit
08
The slide uses a line chart with callout boxes to correlate specific news events with stock price volatility.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
09
Uses a timeline-annotated line chart to frame market volatility as a series of events to be addressed.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
10
The slide uses a simple list format to explain the value proposition of specialty pharmacies followed by a logo grid of industry participants.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
12
The slide uses a value-chain diagram to illustrate the structural change in the supply chain.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
18
The slide uses color-coded boxes to distinguish between entities involved in the timeline events.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
20
The table serves as a precedent for regulatory risk and financial impact in the pharmaceutical industry.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
21
The slide uses a 'villain' framing by contrasting the high penalties of established peers against the absence of the target company (Valeant).Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
23
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
25
The slide uses a quote to contrast the company's public admission of wrongdoing with their internal dismissal of business risk.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
27
The slide uses a structured list format to contrast Valeant's stated answers against the underlying unresolved questions.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
30
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
31
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
32
The slide uses a 'floor' valuation approach to argue for the stock's undervaluation.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
38
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit